NCT06743139

Brief Summary

The cardiovascular complications of sickle cell disease are associated with major morbidity and mortality, as well as impaired quality of life. Stratifying the cardiovascular risk of these patients solely on resting parameters (blood pressure, cardiac ultrasound) is limited. The hypothesis that an exhaustive analysis of the physiological parameters of exercise is launched allows more relevant phenotyping and therefore much better stratification of the individual risk of these patients.. Recent studies have shown a paradigm shift in the use of physical activity. Hitherto inadvisable (acidosis, vaso-occlusive crises), if adapted, moderate and regular, it can lead to functional improvement and a reduction in crises. As a result, cardiovascular exercise rehabilitation is becoming increasingly popular in this population. It's easy to see how effort assessment, particularly through cardiorespiratory exchanges, will become more common in this pathology, making its analysis accessible and interesting.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Mar 2021

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 10, 2021

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 10, 2022

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 11, 2022

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

June 27, 2022

Completed
2.5 years until next milestone

First Posted

Study publicly available on registry

December 19, 2024

Completed
Last Updated

December 19, 2024

Status Verified

July 1, 2023

Enrollment Period

1 year

First QC Date

June 27, 2022

Last Update Submit

December 16, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • To define different clinico-biological profiles in patients with sickle cell disease (HbSS)

    To define different clinico-biological profiles in patients with sickle cell disease (HbSS) by means of an exhaustive physiological analysis coupled with exercise.

    4 weeks

Secondary Outcomes (1)

  • Study resting characteristics to identify at an early stage patients with potential cardiac alterations.

    4 weeks

Interventions

EchographyDIAGNOSTIC_TEST

Simultaneous performance of an echocardiogram (part of the follow-up assessment for sickle cell heart disease) at rest and then during the cardiorespiratory stress test, and an ear capillary lactatemia analysis (already routinely performed to ensure the safety of the cardiorespiratory stress test) during the cardiorespiratory stress test routinely performed at Mondor University Hospital prior to cardiovascular rehabilitation programs.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with homozygous sickle cell disease

You may qualify if:

  • Adult patient ≥ 18 years old
  • Affiliated with a social security scheme (beneficiary or beneficiary's beneficiary)

You may not qualify if:

  • Pregnant or breast-feeding women
  • Patients under guardianship, curatorship or legal protection
  • Patient under AME
  • Patient with a contraindication or unsuitability for physical activity on a cycloergometer

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Assistance Publique Hôpitaux de Paris-Hôpital Henri Mondor

Créteil, Paris, 94010, France

Location

Related Publications (5)

  • Fletcher GF, Ades PA, Kligfield P, Arena R, Balady GJ, Bittner VA, Coke LA, Fleg JL, Forman DE, Gerber TC, Gulati M, Madan K, Rhodes J, Thompson PD, Williams MA; American Heart Association Exercise, Cardiac Rehabilitation, and Prevention Committee of the Council on Clinical Cardiology, Council on Nutrition, Physical Activity and Metabolism, Council on Cardiovascular and Stroke Nursing, and Council on Epidemiology and Prevention. Exercise standards for testing and training: a scientific statement from the American Heart Association. Circulation. 2013 Aug 20;128(8):873-934. doi: 10.1161/CIR.0b013e31829b5b44. Epub 2013 Jul 22. No abstract available.

    PMID: 23877260BACKGROUND
  • http://beh.santepubliquefrance.fr/beh/2015/8/2015_8_2.html

    BACKGROUND
  • Fitzhugh CD, Lauder N, Jonassaint JC, Telen MJ, Zhao X, Wright EC, Gilliam FR, De Castro LM. Cardiopulmonary complications leading to premature deaths in adult patients with sickle cell disease. Am J Hematol. 2010 Jan;85(1):36-40. doi: 10.1002/ajh.21569.

    PMID: 20029950BACKGROUND
  • Hammoudi N, Lionnet F, Redheuil A, Montalescot G. Cardiovascular manifestations of sickle cell disease. Eur Heart J. 2020 Apr 1;41(13):1365-1373. doi: 10.1093/eurheartj/ehz217.

    PMID: 31005979BACKGROUND
  • Guazzi M, Bandera F, Ozemek C, Systrom D, Arena R. Cardiopulmonary Exercise Testing: What Is its Value? J Am Coll Cardiol. 2017 Sep 26;70(13):1618-1636. doi: 10.1016/j.jacc.2017.08.012.

    PMID: 28935040BACKGROUND

MeSH Terms

Interventions

Ultrasonography

Intervention Hierarchy (Ancestors)

Diagnostic ImagingDiagnostic Techniques and ProceduresDiagnosis

Study Officials

  • Thomas D'HUMIERES, Dr

    Henri Mondor University Hospital

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
OTHER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 27, 2022

First Posted

December 19, 2024

Study Start

March 10, 2021

Primary Completion

March 10, 2022

Study Completion

March 11, 2022

Last Updated

December 19, 2024

Record last verified: 2023-07

Data Sharing

IPD Sharing
Will not share

Les données sont la propriété de l'APHP

Locations